Anvisa approves single-dose Butantan vaccine against dengue

There is great hope for the immediate incorporation of this vaccine into the PNI (National Immunization Program). Based on the data presented today, the Ministry of Health should begin discussing incorporation into the SUS tomorrow. Alexandre Padilha, Minister of Health

It will not only be used in our state, in Brazil, but also in the Americas. Butantan already has the capacity to make more than 30 million doses available by mid-2026. And a single-dose vaccine facilitates logistics and increases population adherence. Priscilla Perdicarisacting SP State Secretary of Health

This will create a problem for me, because I’m sure that when I arrive in Washington, in a few days, I will receive calls from all the ministers in the region about when she can arrive. It’s a good problem being created. Jarbas Barbosa, director of Opas (Pan American Health Organization)

Anvisa received a request to register the vaccine on February 6 of this year. Since then, technical demands have been made to the institute team to evaluate the vaccine: one on February 14th (answered on March 7th), one on May 22nd (answered on June 13th) and the last on October 2nd (answered on the 14th of the same month). The analysis was completed on November 18th. The term of commitment signed today provides for the continuity of studies. The next 2 steps are the publication of the registration in the Official Gazette and the signing of the contract between Butantan and the Ministry of Health.

Butantan already has more than one million doses of the new dengue vaccine ready in its factories. From now on, the process is so that the vaccine can be applied through the SUS as quickly as possible. As Alexandre Padilha said, experts will be consulted to decide who will be Butantan-DV’s priority target audience.

The vaccine will be placed on the SUS national calendar starting next year. But 1 million doses are expected to be used in December. And we will work to ensure that the expected 35 million doses arrive as quickly as possible, and not just in the second half of the year. Alexandre Padilha, Minister of Health